These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 7565543)

  • 61. Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis.
    Veenstra J; Veugelers PJ; Keet IP; van der Ven AJ; Miedema F; Lange JM; Coutinho RA
    Clin Infect Dis; 1997 May; 24(5):936-41. PubMed ID: 9142796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Paediatric HIV update.
    Ziegler JB; Palasanthiran P
    J Paediatr Child Health; 1997 Oct; 33(5):373-7. PubMed ID: 9401877
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection.
    Siegel M; Masur H; Kovacs J
    Semin Respir Crit Care Med; 2016 Apr; 37(2):243-56. PubMed ID: 26974301
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Graham SM
    Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
    [No Abstract]   [Full Text] [Related]  

  • 65. Failure of prophylaxis against PCP in patients with HIV infection.
    Bonora S; Di Perri G; Vento S; Cazzadori A; Concia E
    AIDS Patient Care STDS; 1998 Nov; 12(11):843-8. PubMed ID: 11362040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 67. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    JAMA; 1991 Apr; 265(13):1637-40, 1643-4. PubMed ID: 1672167
    [No Abstract]   [Full Text] [Related]  

  • 68. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
    Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
    Sackoff J; McFarland J; Su S; Bryan E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):387-92. PubMed ID: 9833748
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 71. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
    Koletar SL; Heald AE; Finkelstein D; Hafner R; Currier JS; McCutchan JA; Vallee M; Torriani FJ; Powderly WG; Fass RJ; Murphy RL;
    AIDS; 2001 Aug; 15(12):1509-15. PubMed ID: 11504983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 73. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.
    Centers for Disease Control (CDC)
    MMWR Suppl; 1989 Jun; 38(5):1-9. PubMed ID: 2524643
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pneumocystis carinii pneumonia in infants with vertically acquired HIV infection in Switzerland].
    Berger C; Albisetti M; Fanconi S; Rudin C; Cheseaux JJ; Micallef J; Kind C; Nadal D
    Schweiz Med Wochenschr; 1995 Jun; 125(23):1162-7. PubMed ID: 7597404
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pneumocystis carinii pneumonia (PCP) in HIV-infected African children.
    Zar HJ
    SADJ; 2001 Dec; 56(12):617-9. PubMed ID: 11887451
    [No Abstract]   [Full Text] [Related]  

  • 76. Pneumocystis pneumonia in South African children with and without human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Morrow BM; Hsaio NY; Zampoli M; Whitelaw A; Zar HJ
    Pediatr Infect Dis J; 2010 Jun; 29(6):535-9. PubMed ID: 20072079
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paediatric HIV infection.
    Scarlatti G
    Lancet; 1996 Sep; 348(9031):863-8. PubMed ID: 8826814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J; Rubio García R; Antela López A; García Alcaide F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.